NZ740956A - Reversing the effects of the tumor microenvironment using chimeric cytokine receptors - Google Patents
Reversing the effects of the tumor microenvironment using chimeric cytokine receptorsInfo
- Publication number
- NZ740956A NZ740956A NZ740956A NZ74095612A NZ740956A NZ 740956 A NZ740956 A NZ 740956A NZ 740956 A NZ740956 A NZ 740956A NZ 74095612 A NZ74095612 A NZ 74095612A NZ 740956 A NZ740956 A NZ 740956A
- Authority
- NZ
- New Zealand
- Prior art keywords
- reversing
- effects
- tumor microenvironment
- cytokine receptors
- chimeric cytokine
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 102000003675 cytokine receptors Human genes 0.000 title abstract 2
- 108010057085 cytokine receptors Proteins 0.000 title abstract 2
- 230000002463 transducing effect Effects 0.000 abstract 2
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108010002586 Interleukin-7 Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
An immune system cell comprising a chimeric cytokine receptor comprising a cytokine-binding exodomain and a signal transducing endodomain, wherein (a) the exodomain comprises an IL-13 cytokine binding exodomain and an IL-7 signal transducing endodomain. Further discloses treatment of cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161473457P | 2011-04-08 | 2011-04-08 | |
NZ723731A NZ723731A (en) | 2011-04-08 | 2012-04-05 | Reversing the effects of the tumor microenvironment using chimeric cytokine receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ740956A true NZ740956A (en) | 2020-03-27 |
Family
ID=69957764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ740956A NZ740956A (en) | 2011-04-08 | 2012-04-05 | Reversing the effects of the tumor microenvironment using chimeric cytokine receptors |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ740956A (en) |
-
2012
- 2012-04-05 NZ NZ740956A patent/NZ740956A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ723731A (en) | Reversing the effects of the tumor microenvironment using chimeric cytokine receptors | |
PH12019502411A1 (en) | Cells expressing chimeric activitaing receptors and chimeric stimulating receptors and uses thereof | |
WO2012127464A3 (en) | Constitutively activated t cells for use in adoptive cell therapy | |
MX2019013204A (en) | Chimeric cytokine receptor. | |
MX2019010974A (en) | Fc-optimized anti-cd25 for tumour specific cell depletion. | |
MX2020007021A (en) | Treatment of cancer using humanized anti-cd19 chimeric antigen receptor. | |
WO2012150822A3 (en) | Method for receiving downlink signal, and user device, and method for transmitting downlink signal, and base station | |
MX2019006631A (en) | Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells. | |
MX2020001450A (en) | Methods and compositions for reducing immunosupression by tumor cells. | |
EP3467101A3 (en) | Immunotherapy of brain tumor using geneticially engineered gd2-specific t cells | |
MX2014010183A (en) | Compositions and methods for generating a persisting population of t cells useful for the treatment of cancer. | |
MY164661A (en) | Novel immunoconjugates | |
MX349662B (en) | Anti-tumor antigen antibodies and methods of use. | |
ZA201204855B (en) | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use | |
MX2012003521A (en) | Insulin receptor binding antibodies. | |
MX2012001417A (en) | Fully human antibodies to btla. | |
NZ612512A (en) | Use of chimeric antigen receptor-modified t cells to treat cancer | |
NZ626610A (en) | Antibodies that bind csf1r | |
EP2781035A4 (en) | Method and apparatus for transmitting and receiving signals in multi-antenna communication system | |
NZ595641A (en) | Humanized anti-egfl7 antibodies and methods using same | |
MX343659B (en) | Fc RECEPTOR BINDING PROTEINS. | |
MX2012012493A (en) | Modified pyr/pyl receptors activated by orthogonal ligands. | |
MX343580B (en) | Antibodies against g-csfr and uses thereof. | |
GB2492016A (en) | Acoustic transducer with a liquid-filled porous medium backing and methods of making and using same | |
HK1182745A1 (en) | Methods and systems for generating, validating and using monoclonal antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 05 APR 2022 BY PIZZEYS PATENT AND TRADE MARK ATTORNEYS PTY LTD Effective date: 20201007 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 05 APR 2023 BY CPA GLOBAL Effective date: 20220519 |
|
LAPS | Patent lapsed |